medicarereport.org – Page 652 – Your source for breaking news and informational reports on health care

Aetna to sell its Medicare Part D drug plan

In the hopes of winning regulatory approval from the Trump administration, Aetna has agreed to sell its Medicare Part D

(By Alia Paavola for Becker’s Hospital Review) Gilead Sciences will offer a cheaper version of its blockbuster hepatitis C drugs,

(By Morgan Haefner for Becker’s Hospital Review) Blue Cross Blue Shield of Michigan will pay more than 520,000 policyholders for

(By Harrison Cook for Becker’s Hospital Review) Congress revealed a 660-page revised opioids bill the night of Sept. 25 as part of

(By Morgan Haefner for Becker’s Hospital Review) Americans with health insurance coverage through their employer — the largest insured population

With more than 23,000 people dying annually in the United States from bacterial infections that have evolved to resist antibiotics,

An epidemiology professor and her team from the West Virginia University School of Public Health studying the potential benefits of

(By Ed Silverman for STAT) As prices for diabetes treatments continue to roil consumers, a new study suggests that manufacturers

Medicare beneficiaries can change their Medicare Advantage or Medicare Prescription drug (Part D) coverage during the Medicare Annual Election Period

(By Jackie Fortier for NPR) Air ambulance rides can be lifesavers. But how much should they cost? In the ongoing,